Paul Tudor Jones II CTI BioPharma Corp

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$3.52

Avg closing price
Price range
Paul Tudor Jones II Portfolio Stock Details (CTIC)

2 Paul Tudor Jones II CTI BioPharma Trades

Paul Tudor Jones II started to build up the position in CTI BioPharma in Q1 2018. Since then they sold 25 Thousand shares. The investor sold all their shares in Q2 2018 and doesn't own any shares in CTI BioPharma anymore.

Avg closing price
Price range
Sold -25 Thousand shares Q2 2018
Avg closing price $4.38
Price range $3.81 - $5.26
New holding (+25 Thousand shares) Q1 2018
Avg closing price $3.52
Price range $2.70 - $4.06
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.